The single cell sequencing market is estimated to be worth $1,387 million and is expected to grow at compounded annual growth rate (CAGR) of 15% during the forecast period. The anticipated market growth is accredited to the significant surge in demand across the regional and global markets for the products and services offered by the Single cell sequencing Market. The latest study provides readers with a granular analysis of the major developmental elements of the global market, potential business avenues, and the overall market dynamics. The report has been specially curated to offer a deep understanding of the competitive terrain of the global market, highlighting the leading market rivals, their market positions, product portfolios, gross revenue shares, profit margins, pricing analysis, sales network & distribution channels, and financial standing.

Key Players

Active Motif

Admera Health

Annoroad Genomics

BGI Genomics

CD Genomics

MedGenome

Quick Biology

SingulOmics

10x Genomics

Cell Microsystems

Fluidigm

Illumina
Mission Bio

Oxford Nanopore Technologies

Key Geographical Regions

North America

Europe

Asia-Pacific

Rest of the World

The latest research report specializes in the in-depth analysis of the macroeconomic and microeconomic factors affecting the Single cell sequencing Market development. The report also concentrates on the regulatory framework that is shaping the future of the global market. New and existing pricing structures, emerging application areas, and upcoming investment opportunities have also been detailed in the report. The report further studies the projected growth factors that are expected to influence the market dynamics over the forecast timeframe.

The study is inclusive of a comprehensive analysis of the commonly used marketing and promotional strategies adopted by the key market players. Taking into account the existing market development factors, historical events, and recent market trends, the study presents a balanced opinion on the future scenario of the Single cell sequencing Market. It thus supports its opinion by discussing the key corporate strategies, such as mergers & acquisitions, takeovers, joint ventures, and strategic alliances, used by the market players to strengthen their global footprint.

Research Methodology

Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Single cell sequencing Market.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/single-cell-sequencing-market.html

About Roots Analysis

Roots Analysisis a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

Sales@rootsanalysis.com

The report features an extensive study of the current market landscape and future potential of the liposome manufacturing market, over the next decade. In addition, it features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in providing liposome manufacturing. Amongst other elements, the report includes:

An executive summary of the insights captured during our research.

A general overview of liposomes, along with information on the formation and classification of liposome.

A detailed assessment of the overall market landscape of liposome development and manufacturing service providers.

Elaborate profiles of prominent (shortlisted based on a proprietary criterion) players offering liposome manufacturing, across North America, Europe and Asia-Pacific.

A detailed analysis of completed, ongoing and planned clinical studies related to liposomes.

A detailed review of more than 6,000 peer-reviewed, scientific articles related to research on liposomes.

An insightful analysis of the patents filed / granted for liposomes, since 2017.

An in-depth analysis of recent events (webinars / conferences / seminars / workshops / symposiums / summits) that were organized for stakeholders in this domain.

An insightful outsourcing: go / no-go framework analysis, highlighting the various factors that need to be taken into consideration by liposome developers while deciding whether to manufacture their respective products in-house or engage the services of a CMO.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

Type of Product Formulation

Therapeutic

Nutraceutical

Scale of Operation

Discovery / Research

Preclinical

Clinical

Commercial

End User

Pharmaceutical and Biotechnology Industry

Cosmetic Industry

Food Industry

Agricultural Industry

Academics

Other Industries

Key Geographical Regions

North America

Europe

Asia-Pacific

Middle East and North Africa

Latin America

Key companies covered in the report

Baxter BioPharma Solutions

Charles River Laboratories

Evonik

Fresenius Kabi

Fujifilm

GEA

Intertek

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If youd like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Details

Roots Analysis

Gaurav Chaudhary

+1 (857) 387 7999
+44 (748) 188 1310

Gaurav.chaudhary@rootsanalysis.com

Further, the ongoing research has expanded the therapeutic applications of mRNA beyond infectious diseases, to autoimmune disorders, genetic disorders and cancer. However, the mRNA synthesis and manufacturing process is fraught with concerns related to stability, purity, quality and regulatory. Therefore, various companies are increasingly relying on contract manufacturers for their support in the production of mRNA / mRNA-based drugs.

According to Roots Analysis, the mRNA Synthesis and Manufacturing Market is anticipated to be worth USD 1.06 billion in 2024, and this value is likely to be USD 0.58 billion in 2035.

Key Report Takeaways

Presently, over 35 mRNA custom synthesis service providers are available globally; further, most of the players offer mRNA purification services (specifically chromatography and electrophoresis)

More than 40 firms currently claim to offer contract manufacturing services for mRNA as well as mRNA-based products (vaccines and therapeutics); majority of the companies are very large players

Over 95 kits are available in the market for the customized synthesis of mRNA; notably, most of these kits comprise of capping enzymes

To achieve a competitive edge over their competitors, various firms are actively undertaking initiatives to enhance their service as well as product portfolios

Over 70 deals have been forged related to mRNA (since 2019) by various stakeholders; in addition, most of the partnerships were manufacturing agreements

Various big pharma players have undertaken a myriad of initiatives (including collaborations, acquisitions, funding and expansion) for advancing their mRNA-related portfolio and therapeutic applicability

The mRNA synthesis and manufacturing market is anticipated to be driven by the ongoing technological advancements, growing demand for mRNA vaccines (for different indications) and development of innovative mRNA-based therapeutics

Competitive Landscape:

The current market landscape features a mix of over 40 very large, large, mid-sized and small companies, which claim to have the required expertise to offer various services for the contract manufacturing of mRNAs. Around 50% of the players claim to offer contract services for both drug substance (mRNA) and drug product (mRNA-based vaccines and therapeutics).

Competitive Landscape of mRNA Synthesis Kits

The current market landscape features the presence of over 95 kits that are currently available for the synthesis of mRNA. Close to 50% of mRNA synthesis kits contain all the components (including enzyme mix, buffers and other reagents) required to synthesize mRNA. Further, close to 30% of players involved in the mRNA synthesis kit domain are well-established firms; around 65% of the companies are based in North America, followed by Europe (over 20%).

Regional Outlook

Based on the key geographical regions, mRNA synthesis and manufacturing market can be segmented into four major regions, including North America, Europe, Asia Pacific and Rest of the World. North America is anticipated to capture majority share of the mRNA synthesis and manufacturing market in 2024, and this trend is likely to remain unchanged during the forecast period.

mRNA synthesis and manufacturing market Key Players

Examples of key companies engaged in mRNA synthesis and manufacturing market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Aldevron, APExBIO, Aurigene Pharmaceutical Services, Biomay, CELLSCRIPT, Curia, eTheRNA, Enzynomics, Eurogentec, GenScript, Jena Bioscience, Merck KGaA, New England Biolabs, Vernal Biosciences, ST Pharm, Thermo Fisher Scientific, TriLink BioTechnologies, WuXi Biologics.

It is interesting to note that in November 2023, TriLink BioTechnologies launched its Analytical Sciences Center of Excellence (ASCE) to expand its extensive suite of analytical testing capabilities.

mRNA Synthesis and Manufacturing Market Segments

Based on the research, Roots Analysis has segmented the mRNA synthesis and manufacturing market by Type of Product, Application Area, Therapeutic Area and Key Geographical Regions.

by Type of Product

Drug Substance (APIs)

Drug Product (FDFs)

by Application Area

mRNA-based Vaccines

mRNA-based Therapeutics

by Therapeutic Area

Infectious Diseases

Oncological Disorders

Other Disorders

by Key Geographical Regions

North America

Europe

Asia-Pacific

Rest of the World

About Roots Analysis

Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the subject given. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.

Contact US

Gaurav Chaudhary

Email: sales@rootsanalysis.com